tiprankstipranks
Trending News
More News >
Alligator Bioscience AB (SE:ATORX)
:ATORX
Sweden Market

Alligator Bioscience AB (ATORX) Financial Statements

Compare
4 Followers

Alligator Bioscience AB Financial Overview

Alligator Bioscience AB's market cap is currently kr102.73M. The company's EPS TTM is kr-0.663; its P/E ratio is -0.18; Alligator Bioscience AB is scheduled to report earnings on February 12, 2026, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 514.00Kkr 57.77Mkr 58.11Mkr 35.70Mkr 12.94M
Gross Profitkr -110.03Mkr 57.77Mkr 58.11Mkr -112.03Mkr -74.04M
Operating Incomekr -111.73Mkr -229.14Mkr -248.98Mkr -192.79Mkr -141.56M
EBITDAkr -121.98Mkr -165.47Mkr -237.61Mkr -180.99Mkr -130.39M
Net Incomekr -51.35Mkr -233.89Mkr -248.59Mkr -193.40Mkr -141.74M
Balance Sheet
Cash & Short-Term Investmentskr 62.20Mkr 64.31Mkr 66.12Mkr 97.31Mkr 278.15M
Total Assetskr 110.60Mkr 104.34Mkr 118.45Mkr 169.58Mkr 333.20M
Total Debtkr 34.81Mkr 43.57Mkr 16.10Mkr 24.50Mkr 9.74M
Net Debtkr -27.39Mkr -20.74Mkr -50.02Mkr -72.80Mkr -268.41M
Total Liabilitieskr 103.74Mkr 234.93Mkr 106.59Mkr 80.53Mkr 50.93M
Stockholders' Equitykr 6.86Mkr -130.59Mkr 11.86Mkr 89.05Mkr 282.27M
Cash Flow
Free Cash Flowkr -157.45Mkr -212.43Mkr -191.74Mkr -173.05Mkr -127.08M
Operating Cash Flowkr -155.99Mkr -212.43Mkr -189.28Mkr -172.61Mkr -127.03M
Investing Cash Flowkr 2.21Mkr 0.00kr -2.46Mkr -440.00Kkr -45.00K
Financing Cash Flowkr 152.59Mkr 211.27Mkr 161.56Mkr -7.83Mkr 301.80M
Currency in SEK

Alligator Bioscience AB Earnings and Revenue History

Alligator Bioscience AB Debt to Assets

Alligator Bioscience AB Cash Flow

Alligator Bioscience AB Forecast EPS vs Actual EPS